Expresión de marcadores tumorales P16, ciclina D1, BCL2 y Ki67 en cáncer de pene

Hornig E., Álvaro; Troncoso Sch., Luis; Corti O., Dante; Foneron B., Andrónico; Ebel S., Luis; Carrasco L., Cristian; Gil C., Gonzalo; Valdevenito A., Gonzalo.
Rev. chil. urol ; 74(3): 223-228, 2009. ilus, tab
Artículo en Español | LILACS | ID: lil-551918

Documentos relacionados

  1. An unusual penile lesion.
  2. Centralizing Penile Cancer Care in Germany and Austria: Just a Dream or a Fast-Approaching Reality? Results of a Survey Study among Urological Department Chairs and Modeling of Real Treatment Numbers of Penile Cancer Patients.
  3. Differences in overall survival of penile cancer patients versus population-based controls.
  4. Characterization of T cell receptor repertoire in penile cancer.
  5. BIRC5 regulates inflammatory tumor microenvironment-induced aggravation of penile cancer development in vitro and in vivo.
  6. Efficacy of indocyanine green fluorescence-guided inguinal lymph node dissection for penile cancer: a randomised trial.
  7. Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.
  8. [Clinical characteristics and prognostic factors of distant metastatic penile cancer].
  9. The Role of JAK-STAT-SOCS1 Axis in Tumorigenesis, Malignant Progression and Lymphatic Metastasis of Penile Cancer.
  10. [A Case of Secondary Syphilis Mimicking a Penile Cancer with Lymph Node Metastases].